Authors:
Colgan, TJ
Murphy, J
Cole, DEC
Narod, S
Rosen, B
Citation: Tj. Colgan et al., Occult carcinoma in prophylactic oophorectomy specimens - Prevalence and association with BRCA germline mutation status, AM J SURG P, 25(10), 2001, pp. 1283-1289
Authors:
Rahman, N
Arbour, L
Houlston, R
Bonaiti-Pellie, C
Abidi, F
Tranchemontagne, J
Ford, D
Narod, S
Pritchard-Jones, K
Foulkes, WD
Schwartz, C
Stratton, MR
Citation: N. Rahman et al., Penetrance of mutations in the familial Wilms tumor gene FWT1, J NAT CANC, 92(8), 2000, pp. 650-652
Authors:
Esplen, MJ
Toner, B
Hunter, J
Glendon, G
Liede, A
Narod, S
Stuckless, N
Butler, K
Field, B
Citation: Mj. Esplen et al., A supportive-expressive group intervention for women with a family historyof breast cancer: Results of a phase II study, PSYCHO-ONC, 9(3), 2000, pp. 243-252
Authors:
Charames, GS
Millar, AL
Pal, T
Narod, S
Bapat, B
Citation: Gs. Charames et al., Do MSH6 mutations contribute to double primary cancers of the colorectum and endometrium?, HUM GENET, 107(6), 2000, pp. 623-629
Authors:
Kahn, HJ
Yang, LY
Blondal, J
Lickley, L
Holloway, C
Hanna, W
Narod, S
McCready, DR
Seth, A
Marks, A
Marks, A
Citation: Hj. Kahn et al., RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters, BREAST CANC, 60(2), 2000, pp. 143-151
Authors:
Moslehi, R
Russo, D
Phelan, C
Jack, E
Antman, K
Narod, S
Citation: R. Moslehi et al., An unaffected individual from a breast/ovarian cancer family with germlinemutations in both BRCA1 and BRCA2, CLIN GENET, 57(1), 2000, pp. 70-73
Authors:
Baldwin, RL
Nemeth, E
Tran, H
Shvartsman, H
Cass, I
Narod, S
Karlan, BY
Citation: Rl. Baldwin et al., BRCA1 promoter region hypermethylation in ovarian carcinoma: A population-based study, CANCER RES, 60(19), 2000, pp. 5329-5333
Citation: S. Narod, Tamoxifen for prevention of breast cancer: Report of the National SurgicalAdjuvant Breast and Bowel Project P-1 study, J NAT CANC, 91(2), 1999, pp. 188-188
Authors:
Warner, E
Foulkes, W
Goodwin, P
Meschino, W
Blondal, J
Paterson, C
Ozcelik, H
Goss, P
Allingham-Hawkins, D
Hamel, N
Di Prospero, L
Contiga, V
Serruya, C
Klein, M
Moslehi, R
Honeyford, J
Liede, A
Glendon, C
Brunet, JS
Narod, S
Citation: E. Warner et al., Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer, J NAT CANC, 91(14), 1999, pp. 1241-1247
Authors:
Millar, AL
Pal, T
Madlensky, L
Sherman, C
Temple, L
Mitri, A
Cheng, H
Marcus, V
Gallinger, S
Redston, M
Bapat, B
Narod, S
Citation: Al. Millar et al., Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometrium, HUM MOL GEN, 8(5), 1999, pp. 823-829
Authors:
Marcus, VA
Madlensky, L
Gryfe, R
Kim, H
So, K
Millar, A
Temple, LKF
Hsieh, E
Hiruki, T
Narod, S
Bapat, BV
Gallinger, S
Redston, M
Citation: Va. Marcus et al., Immunohistochemistry for hMLH1 and hMSH2: A practical test for DNA mismatch repair-deficient tumors, AM J SURG P, 23(10), 1999, pp. 1248-1255
Authors:
Karlan, BY
Baldwin, RL
Lopez-Luevanos, E
Raffel, LJ
Barbuto, D
Narod, S
Platt, LD
Citation: By. Karlan et al., Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: Implications for ovarian cancer screening, AM J OBST G, 180(4), 1999, pp. 917-925
Authors:
Rahman, N
Abidi, F
Ford, D
Arbour, L
Rapley, E
Tonin, P
Barton, D
Batcup, G
Berry, J
Cotter, F
Davison, V
Gerrard, M
Gray, E
Grundy, R
Hanafy, M
King, D
Lewis, I
Luethy, AR
Madlensky, L
Mann, J
O'Meara, A
Oakhill, T
Skolnick, M
Strong, L
Variend, D
Narod, S
Schwartz, C
Pritchard-Jones, K
Stratton, MR
Citation: N. Rahman et al., Confirmation of FWT1 as a Wilms' tumour susceptibility gene and phenotypiccharacteristics of Wilms' tumour attributable to FWT1, HUM GENET, 103(5), 1998, pp. 547-556